ArticleMolecules (Basel, Switzerland)2024
Enhancing Permanence of Corrosion Inhibitors Within Acrylic Protective Coatings for Outdoor Bronze Using Green Nanocontainers.
Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Outdoor bronze statues are constantly exposed to weather conditions and reactive compounds in the atmosphere that can interact with their surfaces. To avoid these interactions, a commonly used method is the application of coatings with corrosion inhibitors. However, a significant limitation of these inhibitors is their gradual loss over time. In this study, we aimed to improve the durability of 5-ethyl-1,3,4-thiadiazol-2-amine (AEDTA), the inhibitor chosen to formulate new acrylic coatings for outdoor bronzes. Methyl-β-cyclodextrin (Me-β-CD) was selected to host the inhibitor due to the capability of cyclodextrins to form complexes incorporating small organic molecules. The complexes of Me-β-CD and AEDTA were prepared and the inclusion of AEDTA was proved by Fourier-transform infrared spectroscopy, X-ray diffraction and nuclear magnetic resonance spectroscopy. Then, acrylic coatings were prepared at different concentrations of the Me-β-CD/AEDTA system. They were thermally aged and monitored every 24 h. To evaluate the volatilization of the corrosion inhibitor, solid phase microextraction-gas chromatography/mass spectrometry (SPME-GC/MS) and thermal desorption-GC/MS (TD-GC/MS) analyses were performed during the first 72 h. The results were compared to those of pure AEDTA films and Incralac
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.